---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-278642"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2026-06-23T14:09:39+00:00"
generated_at: "2026-06-23T14:10:15.731057+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics stockholders re-elect Garo Armen, Barbara Ryan, John Holcomb as directors; ratify KPMG

## Summary
- Quorum of 3,277,906 shares (65.79% of outstanding) present at annual meeting.
- All three Class II director nominees elected: Garo Armen (2,363,360 for), Barbara Ryan (2,362,760 for), John Holcomb (2,381,491 for).
- Ratification of KPMG as independent auditor for 2026 approved: 3,249,124 for, 26,560 against, 2,222 abstain.
- Broker non-votes of 881,648 on director election; no broker non-votes on auditor ratification.

## SEC filing metadata
- accession: 0001193125-26-278642
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2026-06-23T14:09:39+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000119312526278642/0001193125-26-278642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000119312526278642/inkt-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-278642
- JSON: https://secwatch.observer/filing/0001193125-26-278642.json
- Plain text: https://secwatch.observer/filing/0001193125-26-278642.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.